Nyrada
Drug research and development
Short position
Nyrada (ASX:NYR) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 16 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.06% in September 2026. NYR is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Nyrada (NYR) short interest history
NYR Short Interest History
- 30-day change
- -0.00pp
- 90-day change
- -0.00pp
- 1-year change
- -0.04pp
- All-time high
- 0.06% (September 2026)
- All-time low
- 0.00% (September 2026)
Is NYR heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #774 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has NYR's short interest changed recently?
Over the past 30 days Nyrada's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest NYR's short interest has been?
Since 2024, Nyrada's short interest peaked at 0.06% in September 2026 and bottomed at 0.00% in September 2026.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2024. See our methodology.